Interesting Engineering20h
Lepodisiran drug shows unprecedented 94% drop in heart disease risk factor: Study
Eli Lilly’s experimental drug lepodisiran has shown a 94% reduction in lipoprotein(a) levels, a key genetic risk factor for ...